Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year


IMPACT FACTOR 2017: 3.022

CiteScore 2017: 2.81

SCImago Journal Rank (SJR) 2017: 1.562
Source Normalized Impact per Paper (SNIP) 2017: 0.705

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 395, Issue 9

Issues

Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma

Emmanouela Foteinou
  • Department of Biochemistry and Molecular Biology, University of Athens, GR-15701 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Christos K. Kontos
  • Department of Biochemistry and Molecular Biology, University of Athens, GR-15701 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Aris I. Giotakis
  • First Ear, Nose and Throat Clinics, Athens General Hospital ‘Hippokration’, University of Athens, GR-11527 Athens, Greece
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Andreas Scorilas
  • Corresponding author
  • Department of Biochemistry and Molecular Biology, University of Athens, GR-15701 Athens, Greece
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-04-11 | DOI: https://doi.org/10.1515/hsz-2014-0139

Abstract

Several members of the family of tissue kallikrein and kallikrein-related peptidases have been suggested as promising tumor biomarkers with important prognostic significance. However, only one (KLK11) has already been studied in laryngeal squamous cell carcinoma (LSCC) as a potential biomarker for LSCC diagnosis and/or prognosis. Our study investigated the prognostic value of kallikrein-related peptidase-4 (KLK4) mRNA expression as a molecular tissue biomarker in LSCC. For this purpose, KLK4 mRNA expression analysis was performed in 116 cancerous and 74 paired non-cancerous laryngeal tissue specimens obtained from patients that had undergone surgical treatment for primary LSCC. A remarkable downregulation of KLK4 mRNA expression was discovered in laryngeal tumors, compared to non-cancerous laryngeal tissue specimens. KLK4 mRNA expression was also shown to distinguish LSCC from non-cancerous laryngeal tissues. Furthermore, low KLK4 mRNA expression was shown to predict poor disease-free survival, independently of the histological grade and size of the malignant tumor as well as patient TNM stage. According to Kaplan-Meier survival analysis, low KLK4 mRNA expression predicts short-term relapse even among patients with well-differentiated tumors or those at an early TNM stage. Thus, KLK4 mRNA positivity could be regarded as a novel independent indicator of favorable prognosis for the disease-free survival of LSCC patients.

Keywords: head and neck cancer; kallikreins; molecular tumor biomarkers; oral cancer; prognostic biomarkers; quantitative real-time PCR

References

  • Al-Sarraf, M., LeBlanc, M., Giri, P.G., Fu, K.K., Cooper, J., Vuong, T., Forastiere, A.A., Adams, G., Sakr, W.A., Schuller, D.E., et al. (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J. Clin. Oncol. 16, 1310–1317.Google Scholar

  • Almadori, G., Bussu, F., Gessi, M., Ferrandina, G., Scambia, G., Lauriola, L., Paludetti, G., and Ranelletti, F.O. (2010). Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma. Eur. J. Cancer 46, 1144–1152.CrossrefPubMedGoogle Scholar

  • Bellacosa, A., Almadori, G., Cavallo, S., Cadoni, G., Galli, J., Ferrandina, G., Scambia, G., and Neri, G. (1996). Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin. Cancer Res. 2, 175–180.PubMedGoogle Scholar

  • Borgono, C.A., Gavigan, J.A., Alves, J., Bowles, B., Harris, J.L., Sotiropoulou, G., and Diamandis, E.P. (2007). Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388, 1215–1225.PubMedGoogle Scholar

  • Brenner, J.C., Graham, M.P., Kumar, B., Saunders, L.M., Kupfer, R., Lyons, R.H., Bradford, C.R., and Carey, T.E. (2010). Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 32, 417–426.Google Scholar

  • Camp, R.L., Dolled-Filhart, M., and Rimm, D.L. (2004). X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10, 7252–7259.CrossrefPubMedGoogle Scholar

  • Cheng, S.H., Tsai, S.Y., Yen, K.L., Jian, J.J., Chu, N.M., Chan, K.Y., Tan, T.D., Cheng, J.C., Hsieh, C.Y., and Huang, A.T. (2000). Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J. Clin. Oncol. 18, 2040–2045.Google Scholar

  • Chernock, R.D., Wang, X., Gao, G., Lewis, J.S., Jr., Zhang, Q., Thorstad, W.L., and El-Mofty, S.K. (2013). Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod. Pathol. 26, 223–231.Google Scholar

  • Condon, L.T., Ashman, J.N., Ell, S.R., Stafford, N.D., Greenman, J., and Cawkwell, L. (2002). Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int. J. Cancer 100, 472–475.CrossrefPubMedGoogle Scholar

  • Debela, M., Beaufort, N., Magdolen, V., Schechter, N.M., Craik, C.S., Schmitt, M., Bode, W., and Goettig, P. (2008). Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7. Biol. Chem. 389, 623–632.Google Scholar

  • Dong, Y., Sui, L., Tai, Y., Sugimoto, K., Hirao, T., and Tokuda, M. (2000). Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clin. Cancer Res. 6, 4253–4258.PubMedGoogle Scholar

  • Dong, Y., Sui, L., Sugimoto, K., Tai, Y., and Tokuda, M. (2001). Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int. J. Cancer 95, 209–215.Google Scholar

  • Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., and Parkin, D.M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917.Google Scholar

  • Franchi, A., Gallo, O., Boddi, V., and Santucci, M. (1996). Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin. Cancer Res. 2, 1801–1808.Google Scholar

  • Ganly, I., Talbot, S., Carlson, D., Viale, A., Maghami, E., Osman, I., Sherman, E., Pfister, D., Chuai, S., Shaha, A.R., et al. (2007). Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. J. Clin. Oncol. 25, 1369–1376.CrossrefGoogle Scholar

  • Geomela, P.A., Kontos, C.K., Yiotakis, I., and Scorilas, A. (2013). Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. J. Oral Pathol. Med. 42, 154–161.CrossrefGoogle Scholar

  • Gratio, V., Beaufort, N., Seiz, L., Maier, J., Virca, G.D., Debela, M., Grebenchtchikov, N., Magdolen, V., and Darmoul, D. (2010). Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am. J. Pathol. 176, 1452–1461.CrossrefGoogle Scholar

  • Guo, Y., Chen, J.X., Yang, S., Fu, X.P., Zhang, Z., Chen, K.H., Huang, Y., Li, Y., Xie, Y., and Mao, Y.M. (2010). Selection of reliable reference genes for gene expression study in nasopharyngeal carcinoma. Acta Pharmacol. Sin. 31, 1487–1494.CrossrefPubMedGoogle Scholar

  • Iqbal, A., Warraich, R., Udeabor, S., Rana, M., Eckardt, A., Gellrich, N.C., and Rana, M. (2013). Role of human papillomavirus infection and other factors in patients with head and neck squamous cell carcinoma. Oral. Dis. 20, 288–293.PubMedGoogle Scholar

  • Ishige, S., Kasamatsu, A., Ogoshi, K., Saito, Y., Usukura, K., Yokoe, H., Kouzu, Y., Koike, H., Sakamoto, Y., Ogawara, K., et al. (2013). Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer. Mol. Carcinog. Jan 31, doi: 10.1002/mc.22007.CrossrefGoogle Scholar

  • Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010). Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300.Google Scholar

  • Jerjes, W., Upile, T., Petrie, A., Riskalla, A., Hamdoon, Z., Vourvachis, M., Karavidas, K., Jay, A., Sandison, A., Thomas, G.J., et al. (2010). Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2, 9.Google Scholar

  • Jiang, R., Shi, Z., Johnson, J.J., Liu, Y., and Stack, M.S. (2011). Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J. Biol. Chem. 286, 9127–9135.Google Scholar

  • Jin, Y.T., Kayser, S., Kemp, B.L., Ordonez, N.G., Tucker, S.L., Clayman, G.L., Goepfert, H., Luna, M.A., Batsakis, J.G., and El-Naggar, A.K. (1998). The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82, 2159–2165.Google Scholar

  • Kontos, C.K. and Scorilas, A. (2012). Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin. Chem. Lab. Med. 50, 1877–1891.PubMedGoogle Scholar

  • Kontos, C.K., Chantzis, D., Papadopoulos, I.N., and Scorilas, A. (2013). Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients. Cancer Lett. 330, 106–112.Google Scholar

  • Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1–14.Google Scholar

  • Lallemant, B., Evrard, A., Combescure, C., Chapuis, H., Chambon, G., Raynal, C., Reynaud, C., Sabra, O., Joubert, D., Hollande, F., et al. (2009). Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol. Biol. 10, 78.CrossrefPubMedGoogle Scholar

  • Li, Z., Bian, L.J., Li, Y., Liang, Y.J., and Liang, H.Z. (2009). Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis. Pathol. Res. Pract. 205, 542–550.Google Scholar

  • Li, C., Chen, L., Wang, J., Zhang, L., Tang, P., Zhai, S., Guo, W., Yu, N., Zhao, L., Liu, M., et al. (2011). Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer. Oncol. Rep. 26, 869–875.PubMedGoogle Scholar

  • Liu, M., Lawson, G., Delos, M., Jamart, J., Ide, C., Coche, E., Weynand, B., Desuter, G., Hamoir, M., Remacle, M., et al. (2003). Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck 25, 280–288.Google Scholar

  • Liu, Y., Gilcrease, M.Z., Henderson, Y., Yuan, X.H., Clayman, G.L., and Chen, Z. (2001). Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett. 169, 173–180.Google Scholar

  • Livak, K.J. and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.Google Scholar

  • Llewellyn, C.D., Johnson, N.W., and Warnakulasuriya, K.A. (2001). Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol. 37, 401–418.PubMedCrossrefGoogle Scholar

  • Lothaire, P., de Azambuja, E., Dequanter, D., Lalami, Y., Sotiriou, C., Andry, G., Castro, G., Jr., and Awada, A. (2006). Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 28, 256–269.Google Scholar

  • Maurizi, M., Scambia, G., Benedetti Panici, P., Ferrandina, G., Almadori, G., Paludetti, G., De Vincenzo, R., Distefano, M., Brinchi, D., Cadoni, G., et al. (1992). EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int. J. Cancer 52, 862–866.CrossrefGoogle Scholar

  • Maurizi, M., Almadori, G., Cadoni, G., Scambia, G., Ottaviani, F., Ferrandina, G., Paludetti, G., D’Abramo, G., and Mancuso, S. (1996). Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis. Int. J. Cancer 69, 105–109.Google Scholar

  • Mavridis, K. and Scorilas, A. (2010). Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Future Oncol. 6, 269–285.CrossrefPubMedGoogle Scholar

  • Nadal, A., Campo, E., Pinto, J., Mallofre, C., Palacin, A., Arias, C., Traserra, J., and Cardesa, A. (1995). p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J. Pathol. 175, 181–188.Google Scholar

  • Narayana, A., Vaughan, A.T., Gunaratne, S., Kathuria, S., Walter, S.A., and Reddy, S.P. (1998). Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82, 286–291.Google Scholar

  • Obiezu, C.V., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G.M., Fracchioli, S., Rigault de la Longrais, I.A., Arisio, R., and Diamandis, E.P. (2001). Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res. 7, 2380–2386.Google Scholar

  • Osman, I., Sherman, E., Singh, B., Venkatraman, E., Zelefsky, M., Bosl, G., Scher, H., Shah, J., Shaha, A., Kraus, D., et al. (2002). Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J. Clin. Oncol. 20, 2980–2987.CrossrefGoogle Scholar

  • Pan, Y. and Claret, F.X. (2012). Targeting Jab1/CSN5 in nasopharyngeal carcinoma. Cancer Lett. 326, 155–160.Google Scholar

  • Papachristopoulou, G., Avgeris, M., and Scorilas, A. (2009). Expression analysis and study of KLK4 in benign and malignant breast tumours. Thromb. Haemost. 101, 381–387.Google Scholar

  • Patsis, C., Glyka, V., Yiotakis, I., Fragoulis, E.G., and Scorilas, A. (2012a). l-DOPA decarboxylase (DDC) expression status as a novel molecular tumor marker for diagnostic and prognostic purposes in laryngeal cancer. Transl. Oncol. 5, 288–296.PubMedCrossrefGoogle Scholar

  • Patsis, C., Yiotakis, I., and Scorilas, A. (2012b). Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. Clin. Biochem. 45, 623–630.CrossrefGoogle Scholar

  • Pignataro, L., Pruneri, G., Carboni, N., Capaccio, P., Cesana, B.M., Neri, A., and Buffa, R. (1998). Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J. Clin. Oncol. 16, 3069–3077.Google Scholar

  • Pruneri, G., Pignataro, L., Carboni, N., Buffa, R., Di Finizio, D., Cesana, B.M., and Neri, A. (1999). Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. J. Clin. Oncol. 17, 3150–3159.Google Scholar

  • Pruneri, G., Pignataro, L., Valentini, S., Fabris, S., Maisonneuve, P., Carboni, N., Pece, S., Capra, M., Del Curto, B., Neri, A., et al. (2005). Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma. Clin. Cancer Res. 11, 242–248.Google Scholar

  • Puente, X.S., Sanchez, L.M., Overall, C.M., and Lopez-Otin, C. (2003). Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544–558.CrossrefPubMedGoogle Scholar

  • Saito, K., Inagaki, K., Kamimoto, T., Ito, Y., Sugita, T., Nakajo, S., Hirasawa, A., Iwamaru, A., Ishikura, T., Hanaoka, H., et al. (2013). MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS One 8, e71480.Google Scholar

  • Sankaranarayanan, R., Masuyer, E., Swaminathan, R., Ferlay, J., and Whelan, S. (1998). Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 18, 4779–4786.PubMedGoogle Scholar

  • Scambia, G., Panici, P.B., Battaglia, F., Ferrandina, G., Almadori, G., Paludetti, G., Maurizi, M., and Mancuso, S. (1991). Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer 67, 1347–1351.Google Scholar

  • Schmittgen, T.D. and Livak, K.J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101–1108.CrossrefPubMedGoogle Scholar

  • Shiga, K., Ogawa, T., Katagiri, K., Yoshida, F., Tateda, M., Matsuura, K., and Kobayashi, T. (2012). Differences between oral cancer and cancers of the pharynx and larynx on a molecular level. Oncol. Lett. 3, 238–243.PubMedGoogle Scholar

  • Sullu, Y., Gun, S., Atmaca, S., Karagoz, F., and Kandemir, B. (2010). Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. Diagn. Pathol. 5, 35.PubMedCrossrefGoogle Scholar

  • Swellam, M., El-Arab, L.R., and Adly, A. (2008). Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma. Clin. Biochem. 41, 1059–1066.PubMedCrossrefGoogle Scholar

  • Tan, O.L., Whitbread, A.K., Clements, J.A., and Dong, Y. (2006). Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? Biol. Chem. 387, 697–705.Google Scholar

  • Teknos, T.N., Cox, C., Yoo, S., Chepeha, D.B., Wolf, G.T., Bradford, C.R., Carey, T.E., and Fisher, S.G. (2002). Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 24, 1004–1011.PubMedGoogle Scholar

  • Tomasino, R.M., Daniele, E., Bazan, V., Morello, V., Tralongo, V., Nuara, R., Nagar, C., Salvato, M., Ingria, F., Restivo, S., et al. (1995). Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res. 55, 6103–6108.Google Scholar

  • Vogel, C. and Marcotte, E.M. (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227–232.PubMedGoogle Scholar

  • Warnakulasuriya, S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309–316.PubMedCrossrefGoogle Scholar

  • Yousef, G.M., Luo, L.Y., and Diamandis, E.P. (1999). Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res. 19, 2843–2852.Google Scholar

  • Yousef, G.M., Chang, A., Scorilas, A., and Diamandis, E.P. (2000). Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125–133.Google Scholar

  • Zhang, X., Hunt, J.L., Landsittel, D.P., Muller, S., Adler-Storthz, K., Ferris, R.L., Shin, D.M., and Chen, Z.G. (2004). Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin. Cancer Res. 10, 8451–8459.CrossrefGoogle Scholar

  • Zhao, H., Dong, Y., Quan, J., Smith, R., Lam, A., Weinstein, S., Clements, J., Johnson, N.W., and Gao, J. (2011). Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma. Head Neck 33, 566–572.PubMedGoogle Scholar

  • Zhao, X.D., Zhang, W., Liang, H.J., and Ji, W.Y. (2013). Overexpression of miR-155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One 8, e56395.Google Scholar

About the article

Corresponding author: Andreas Scorilas, Department of Biochemistry and Molecular Biology, University of Athens, GR-15701 Athens, Greece, e-mail:


Received: 2014-02-15

Accepted: 2014-04-08

Published Online: 2014-04-11

Published in Print: 2014-09-01


Citation Information: Biological Chemistry, Volume 395, Issue 9, Pages 1051–1062, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/hsz-2014-0139.

Export Citation

©2014 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Panagiotis G. Adamopoulos, Christos K. Kontos, and Andreas Scorilas
Scientific Reports, 2017, Volume 7, Number 1
[3]
Carola H. Schrader, Markus Kolb, Karim Zaoui, Christa Flechtenmacher, Niels Grabe, Klaus-Josef Weber, Thomas Hielscher, Peter K. Plinkert, and Jochen Hess
Molecular Cancer, 2015, Volume 14, Number 1

Comments (0)

Please log in or register to comment.
Log in